GRK2 and cancer: Recent studies have shown that TNF-α stimulates FLS; TNF-α receptor 2 transactivates GRK2 via TRAF2, promoting desensitization of EP4 receptors, which leads to cancer-like proliferation of FLS and contributes to disease progression in RA [38].